Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
Innovent and Lilly Expand Strategic Partnership in Oncology
March 27, 2022 -
Business Wire
WellAir Launches a New Advanced Air Cleaning Device in Europe with Independently Tested Industry Leading 99.9% Effectiveness Against Airborne Pathogens
March 22, 2022 -
PR Newswire
AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic ‘RelieVRx’ and Announces Three-month Durability Study Results
March 22, 2022 -
PR Newswire
Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats
March 22, 2022 -
Fierce Healthcare
Carrot Fertility rolls out age-inclusive benefits for menopause, low testosterone
March 16, 2022 -
PR Newswire
WellHive Announces Partnership with Kyruus to Integrate Systems and Optimize Care Navigation for Veterans
March 10, 2022 -
Globenewswire
Equip and Magellan Healthcare Collaborate to Offer Virtual Eating Disorder Treatment in California
March 10, 2022 -
Business Wire
Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors
March 10, 2022 -
Business Wire
UPMC and Kyruus Launch Strategic Partnership to Transform Digital Patient Access and Care Navigation
March 9, 2022 -
PR Newswire
Proximie Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
March 3, 2022 -
Globenewswire
Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
March 2, 2022 -
PR Newswire
Rialtic Completes Series A Extension Bringing Total Round to $45 Million
March 2, 2022 -
PR Newswire
Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target
February 24, 2022 -
Forbes
Benchling Expands Its Science Software Capabilities With Its First Acquisition
February 24, 2022 -
PR Newswire
Avidity Biosciences Appoints Steve Hughes, M.D., as Chief Medical Officer
February 23, 2022 -
PR Newswire
Independence Blue Cross and Patina announce agreement to offer Medicare Advantage members a new primary care experience
February 22, 2022 -
PR Newswire
Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345
February 20, 2022 -
Business Wire
NOCD Selects Violet to Enhance Cultural and Identity Awareness Training to Therapists To Deliver More Personalized Care
February 16, 2022 -
GlobeNewswire
Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment
February 16, 2022 -
Fierce Healthcare
Expressable grabs $15M to expand access to online speech therapy
February 9, 2022 -
PR Newswire
Centivo survey reveals devastating toll of the healthcare affordability crisis on US workers
February 8, 2022 -
PR Newswire
EmpiRx Health Reaffirms Commitment to Employees, Partners with Valor Performance to Strengthen Leadership & Employee Experience
February 4, 2022 -
Business Wire
Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care
February 3, 2022 -
PR Newswire
AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome
February 3, 2022 -
GlobeNewswire
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
February 3, 2022 -
Business Wire
Four Seasons Astir Palace Hotel Partners with WellAir to Improve Indoor Air Quality
February 1, 2022 -
PR Newswire
Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform
January 25, 2022 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy
January 24, 2022 -
Endpoints News
F-Prime backed startup nabs another $50M in bid to scale up AI R&D software
January 24, 2022 -
BioSpace
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors
January 20, 2022 -
GlobeNewswire
CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development
January 20, 2022 -
Business Wire
WellAir Announces Strategic Partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)
January 20, 2022 -
Business Wire
ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
January 20, 2022 -
PR Newswire
Icon Health Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
January 19, 2022 -
Business Wire
Ami Bavishi Joins Rallybio to Lead Investor Relations and Corporate Communications
January 18, 2022 -
Business Wire
Fort HealthCare Partners with Ivenix to Provide Unprecedented Infusion Safety
January 13, 2022 -
PR Newswire
Health Care Leader Jay Meyers Joins Quartet Health as Chief Growth Officer to Accelerate National Growth to Deliver Speed to Quality Mental Health Care for All
January 13, 2022 -
GlobeNewswire
Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinical Trial of ADG106 in Combination with Nivolumab in Singapore
January 13, 2022 -
GlobeNewswire
Wellframe Achieves Momentous Growth in 2021, Accelerating Its Ability to Modernize the Member Experience
January 12, 2022 -
Business Wire
SonderMind Announces Appointment of Brannan Schell to New Chief Operating Officer Position
January 12, 2022 -
PR Newswire
Global Health Technology Platform – Proximie – Announces Partnership With Vodafone Business to Increase Access to Surgical Healthcare and Training
January 11, 2022 -
PR Newswire
Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets
January 11, 2022 -
GlobeNewswire
Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct
January 11, 2022 -
FierceBiotech
Pfizer re-ups gene editing interest with $300M Beam pact, $1.35B in biobucks
January 10, 2022 -
GlobeNewswire
Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
January 10, 2022 -
PR Newswire
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
January 10, 2022 -
PR Newswire
Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
January 9, 2022 -
PR Newswire
RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents
January 6, 2022 -
Business Wire
Nomi Health Acquires Artemis Health to Accelerate Transformation of U.S. Healthcare with Actionable Insights
January 6, 2022 -
PR Newswire
Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation
January 5, 2022 -
Renaissance Capital Report
Gene therapy biotech Affinia Therapeutics files for a $100 million IPO
January 4, 2022 -
PR Newswire
TraceLink Wins Comparably 2021 Best Company Culture Award
January 4, 2022 -
GlobeNewswire
Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH
December 17, 2021 -
FierceBiotech
Amgen, Owkin study shows cardiac-predicting AI outperforms traditional clinical methods
December 17, 2021 -
GlobeNewswire
Singular Genomics Launches the G4 Sequencing Platform
December 16, 2021 -
PR Newswire
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
December 16, 2021 -
GlobeNewswire
Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer
December 14, 2021 -
Business Wire
Virtua Health Selects Kyruus’ Digital Platform to Simplify How Consumers Access Care Online
December 14, 2021 -
PR Newswire
Quartet Health Acquires InnovaTel Telepsychiatry, Making Shared Vision of Speed to Quality Mental Health Care for All a Reality
December 13, 2021 -
GlobeNewswire
Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment
December 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data Showcasing Best-in-Class Profiles for ADG153, an Anti-CD47 SAFEbody® and ADG152, a CD20xCD3 Bispecific T-cell Engager POWERbody™
December 13, 2021 -
FierceHealthcare
Quartet picks up InnovaTel Telepsychiatry to expand its reach in the digital mental health market
December 13, 2021 -
GlobeNewswire
Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH
December 12, 2021 -
GlobeNewswire
Carrot Fertility Expands Executive Team, Hires Former Aetna Executive as Chief Commercial Officer
December 9, 2021 -
PR Newswire
1upHealth Named as “Most Innovative Digital Health Startup” by CB Insights’ Digital Health 150
December 9, 2021 -
MobiHealthNews
Quartet Health snaps up fellow mental health company InnovaTel Telepsychiatry
December 9, 2021 -
PR Newswire
Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care
December 9, 2021 -
Endpoints News
Atlas, F-Prime launch K36 Therapeutics to advance oncology molecule for elusive epigenetic target
December 9, 2021 -
Business Wire
NOCD Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
December 8, 2021 -
Business Wire
HealthEdge Completes Acquisition of Wellframe
December 7, 2021 -
Business Wire
Ochsner Health Makes Finding the Right Provider Easier with Solutions from Kyruus
December 7, 2021 -
PR Newswire
Stride partners with 100+ flexible work platforms and employers in support of “Gig Workers’ Week of Action” to boost health insurance enrollment before Dec. 15th deadline
December 6, 2021 -
PR Newswire
Nature Medicine Publishes Results from Two Registration Studies of AYVAKIT® (avapritinib) Showing Sustained Benefits in Patients with Advanced Systemic Mastocytosis
December 6, 2021 -
Business Wire
CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients
December 6, 2021 -
PR Newswire
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
December 2, 2021 -
PR Newswire
Independence Health Group and Quartet Health Announce Strategic Partnership to Drive Speed to Mental Health Care
December 2, 2021 -
PR Newswire
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
December 2, 2021 -
GlobeNewswire
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
December 2, 2021 -
AviadoBio
AviadoBio™ Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform
December 2, 2021 -
Business Wire
Fiverr Teams Up With Stride Health to Help Fiverr Community Access Affordable Healthcare
December 1, 2021 -
Business Wire
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
December 1, 2021 -
GlobeNewswire
Surface Oncology Announces FDA Clearance of IND Application for GSK4381562, a Novel Antibody Targeting PVRIG
December 1, 2021 -
GlobeNewswire
Ultragenyx Announces First Patient Dosed in Phase 1/2 Clinical Study of UX053, an mRNA Therapy for the Treatment of Glycogen Storage Disease Type III
December 1, 2021 -
PR Newswire
Avivomed Raises $32 Million in Series A Financing
December 1, 2021 -
PR Newswire
Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico’s Proprietary End-to-end Artificial Intelligence Platform
November 30, 2021 -
Business Wire
Turnstone Biologics Announces Research Collaboration with Moffitt Cancer Center to Advance Novel TIL Immunotherapies for Solid Tumor Indications
November 29, 2021 -
GlobeNewswire
Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab
November 29, 2021 -
GlobeNewswire
Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer
November 29, 2021 -
GlobeNewswire
Ultragenyx Announces Additional Positive Multi-Year Durability Data from Phase 1/2 AAV Gene Therapy Studies
November 29, 2021 -
FierceBiotech
Cloud R&D developer Benchling picks up second nine-figure venture capital haul this year
November 19, 2021
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.